CAH

CAH N/A N/A

Back to Search

$0.00

+$0.00 (+0.00%)

Open: $0.00 | High: $0.00 | Low: $0.00 | Prev Close: Prev Close: $0.00

Market Cap: N/A

Volume: N/A | Avg: N/A

Last updated: April 09, 2026 at 06:01 PM
Investment Rating
B-

Sell

Overall Score: 40/100


Rating Breakdown:
DCF Score 4/5
80%
Buy
ROE Score 1/5
20%
Strong Sell
ROA Score 5/5
100%
Strong Buy
D/E Score 1/5
20%
Strong Sell
P/E Score 2/5
40%
Sell
P/B Score 1/5
20%
Strong Sell

Stock Score Analysis
E

Stock Score: 517

Comprehensive Quality Assessment


Component Breakdown:
Efficiency 20
Financial Health 50
Growth 50
Market Sentiment 0
Risk 50
Lower is better
Valuation 7
Momentum 40

Valuation Metrics
Valuation Ratios
P/E Ratio 30.76
P/B Ratio -18.98
P/S Ratio 0.21
EPS $7.06
Beta
Shares Outstanding N/A

Price Range & Moving Averages
52-Week High $
52-Week Low $
SMA 50 $
SMA 200 $
Financial Ratios
Margins
Gross Margin 3.6%
Operating Margin 1.0%
Net Margin 0.7%

Returns
ROE -58.9%
ROA 2.9%

Liquidity & Leverage
Debt/Equity -3.34
Current Ratio 0.91
Quick Ratio 0.44
Balance Sheet
Total Assets $53.12B
Total Liabilities $55.76B
Total Equity $-2,781,000,000

Cash $3.87B
Total Debt $9.35B
Net Debt $5.47B
Income Statement
Revenue $222.58B
Gross Profit $8.17B
Operating Income $2.27B
Net Income $1.56B

EBITDA $3.11B
Revenue/Share $1035.96
Cash Flow
Operating CF $2.40B
CapEx $547.00M
Free Cash Flow $1.85B

Book Value/Share $-11.44
Tangible Book/Share $-70.67
Equity/Share $-11.44
Technical Indicators
RSI (14) 53.40 Neutral
MACD
-1.19 Signal: -1.91
Volatility 20.62%
Trading Signal Bullish
Performance & Returns

Insufficient historical data

Invalid current price
Sector Comparison

Sector comparison unavailable

No sector data available
📊 Historical Price Analysis (Last 200 Days)
Loading chart...

Loading chart...

Technical Analysis
Ticker Close SMA 5 SMA 8 SMA 13 SMA 50 SMA 200 RSI (14) MACD Volatility (%) Volume Signal SMA Decision
CAH $0.00 $214.06 $212.11 $211.25 $217.88 $185.71 53.40 -1.19 20.62% 393889 Strong Long Bullish Stack
Candlestick Patterns

There wasn't any recognizable pattern for the CAH stock

News Sentiment
Ticker Headline Sentiment Source URL
CAH Abacus FCF Advisors LLC Buys New Position in Cardinal Health, Inc. $CAH Neutral defenseworld.net Read More
CAH Why Congress Can't Stop Loading Up on These 3 Stocks in 2026 Neutral 247wallst.com Read More
CAH Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth Positive zacks.com Read More
CAH Are Investors Undervaluing Cardinal Health (CAH) Right Now? Neutral zacks.com Read More
CAH Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade Positive zacks.com Read More
Recent Insider Trading

No recent insider trading data available for CAH

Company Information

CAH is a company in the N/A sector.


CEO N/A
Employees
Country N/A
IPO Date N/A
Exchange N/A
Sector N/A
Industry N/A
Rating Metrics Explained
DCF Score (Discounted Cash Flow)

Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.

ROE Score (Return on Equity)

Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.

ROA Score (Return on Assets)

Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.

D/E Score (Debt-to-Equity)

Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.

P/E Score (Price-to-Earnings)

Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.

P/B Score (Price-to-Book)

Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.


Rating Recommendations:

Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:

  • Strong Buy (5/5): Excellent score - strong positive indicator
    • The metric significantly outperforms industry averages (top 20% of companies)
    • Indicates exceptional financial health or attractive valuation in that category
  • Buy (4/5): Good score - positive indicator
    • Above-average performance (top 40% of companies)
    • Shows strong fundamentals with room for improvement
  • Neutral (3/5): Average score - neutral indicator
    • Performance in line with industry median (middle 20%)
    • Neither significantly positive nor negative signal
  • Sell (2/5): Below average - negative indicator
    • Below-average performance (bottom 40% of companies)
    • Suggests weakness in this particular metric
  • Strong Sell (1/5): Poor score - strong negative indicator
    • Significantly underperforms industry (bottom 20%)
    • Indicates potential risk or overvaluation in that category
Note: The overall rating combines all six component scores to provide a comprehensive investment assessment. No single metric should be used in isolation for investment decisions.